720-777-0123
- Your Visit
-
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
Adam Green, MD
- Attending Physician
- Hematology/Oncology - Pediatric
- Pediatrics
I am committed to providing exceptional child- and family-centered care to my patients. I strive to communicate information truthfully to families at all times, and in an age-appropriate way to patients throughout childhood. As part of a team that includes physicians, nurse practitioners, nurses, social workers, and others, I aim to provide the highest quality, most innovative care to all patients from Colorado and beyond, to maximize cure rates and minimize adverse effects of treatment.
Get to know Adam Green, MD
- Brain Tumors
- Pediatric Cancer
- Craniopharyngioma
- English
- Spanish
I help lead national clinical trials and give second opinions for other institutions for pediatric high-grade glioma, diffuse intrinsic pontine glioma (DIPG), and diffuse midline glioma. I also specialize in the diagnosis and management of other childhood tumors of the brain and spinal cord. In addition, I have expertise in other childhood cancers, benign blood disorders, and stem cell transplant.
Undergraduate 2002
Dartmouth College (NH)
Medical Education 2006
New York University School of Medicine
Internship 2007
University of Colorado (Children's Hospital Colorado) Program
Residency 2009
University of Colorado (Children's Hospital Colorado) Program
Residency 2010
University of Colorado (Children's Hospital Colorado) Program
Fellowship 2013
Dana-Farber Cancer Institute/Boston Children’s Hospital/Harvard Medical School Program
Website: http://www.ncbi.nlm.nih.gov/myncbi/browse/collection/47017224/?sort=date&direction=ascending
For Patients:
My research focuses on a specific type of cancer called high-grade glioma, an aggressive brain tumor affecting both children and adults. We focus especially on two pediatric subtypes called diffuse intrinsic pontine glioma and pediatric glioblastoma. I work in the lab to find new treatments for these tumors; we then study the treatments in laboratory models of the tumors, including mouse models, and then bring the treatments most likely to be successful to clinical trials in children.
My research focuses on a specific type of cancer called high-grade glioma, an aggressive brain tumor affecting both children and adults. We focus especially on two pediatric subtypes called diffuse intrinsic pontine glioma and pediatric glioblastoma. I work in the lab to find new treatments for these tumors; we then study the treatments in laboratory models of the tumors, including mouse models, and then bring the treatments most likely to be successful to clinical trials in children.
For Referring Providers:
My research focuses on novel targets and therapies for pediatric high-grade glioma, including diffuse intrinsic pontine glioma, and by extension, adult high-grade glioma as well. In my lab, we work to discover and exploit innovative, rational targets in these tumors, and to bring novel treatments against these targets through laboratory models of these diseases to early-phase clinical trials.
My research focuses on novel targets and therapies for pediatric high-grade glioma, including diffuse intrinsic pontine glioma, and by extension, adult high-grade glioma as well. In my lab, we work to discover and exploit innovative, rational targets in these tumors, and to bring novel treatments against these targets through laboratory models of these diseases to early-phase clinical trials.
Young Investigator Award 2017
Awarded to two pediatric hematology-oncology investigators in the United States each year for early career research accomplishment
American Society of Pediatric Hematology-Oncology
Angie Peltz, PA-C
Physician Assistant
Taizo Nakano, MD
Hematology/Oncology - Pediatric, Pediatrics
Craig Forester, MD
Hematology/Oncology - Pediatric, Pediatrics
